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ABSTRACT: 
The incidence of new HIV infections occurring globally each day is about 
14,000 of which more than 95% are in developing countries. The cumulative 
lifetime risk of developing ocular manifestation in HIV positive person is found to 
be between 52 to 100 % in various studies. 
 OBJECTIVES: 
1. To define the ocular manifestations of HIV/AIDS in adults at the time of 
diagnosis. 
2. To determine the prevalence of ocular manifestations of HIV/AIDS in adults 
at the time of diagnosis 
3. To correlate the manifestations with the demographic profile and clinical 
stage of the disease. 
4. To determine the visual impairment associated with ocular manifestations. 
MATERIALS AND METHODS: 
A total of 76 persons who were diagnosed recently as HIV positive and 
attended the OP clinic of department of STD (sexually transmitted diseases) and 
ART centre were screened for ophthalmic status with resources provided after 
getting a clear consent. 
RESULTS: 
Among the 76 persons examined 30 had ocular lesions; of which 26 had 
HIV related ocular manifestations and 4 had HIV non related ocular manifestation. 
12 had posterior segment,6  had anterior segment lesions, 6 had adnexal lesions, 
while 2 had Neuro ophthalmological lesions. HIV retinopathy is the most common 
isolated ocular manifestation found in about 10 persons.  
CONCLUSION: 
The prevalence of ocular manifestations occuring in adults at the time of 
diagnosis was24.34%. No significant association was found with the demographic 
profile, mode of transmission and concurrent history of tuberculosis. Though, 
significant association was found with clinical stage of the disease and the 
concomitant presence of ocular symptoms. The prevalence of visual impairment 
due to HIV associated ocular manifestation is around 6.57%. Hence, the present 
study strongly emphasizes the importance of routine ophthalmic screening at the 
time of diagnosis of HIV seropositivity in adults. 
KEYWORDS: 
 Human immunodeficiency virus,  CD4 count, WHO staging, HIV 
retinopathy, Herpes zoster Ophthalmicus, Visual impairment. 
  
                                 LIST OF PICTURES 
S.NO NAME OF THE PICTURE PAGE NO 
1. 
Structure of HIV – Electron microscopic 
view 
5 
2. Choroidal tuberculoma 97 
3. Herpes zoster keratouveitis 98 
4. Chronic keratitis 98 
5. Squamous cell carcinoma of conjunctiva 99 
6. HIV retinopathy 100 
 
 
 
 
 
 
  
                                          LIST OF CHARTS    
S.NO NAME OF THE CHART PAGE  
1. AGE DISTRIBUTION 46 
2. SEX DISTRIBUTION 42 
3. SOCIO ECONOMIC STATUS DISTRIBUTION 44 
4. MARITAL STATUS DISTRIBUTION 48 
5. MODE OF TRANSMISSION 50 
6. CLINICAL STAGE OF THE DISEASE 54 
7. CD4 COUNT DISTRIBUTION 56 
8. TUBERCULOSIS HISTORY 52 
9. VISUAL ACUITY – RIGHT EYE/LEFT EYE 62 
10. LIDS AND ADNEXA FINDINGS 68 
11. ANTERIOR SEGMENT FINDINGS 71 
12. POSTERIOR SEGMENT FINDINGS 74 
13. VISUAL FIELDS 77 
14. SCHIRMERS TEST 79 
15. FINAL OPHTHALMIC STATUS 84 
 
  
TABLE OF CONTENTS 
S.NO TITLE PAGE NO 
1. ACKNOWLEDGEMENT  
2. LIST OF PICTURES  
3. LIST OF CHARTS  
4. INTRODUCTION 1 
5. REVIEW OF LITERATURE 3 
6. OBJECTIVES OF THE STUDY 31 
7. MATERIALS AND METHODS 32 
8. STATISTICAL ANALYSIS 42 
9. RESULTS - CONSOLIDATION 85 
10. DISCUSSION 87 
11. SUMMARY 93 
12. CONCLUSION 95 
13. CLINICAL PICTURES 97 
14. 
ANNEXURES: 
BIBLIOGRAPHY 
THESIS PROFORMA 
KEY TO MASTER CHART 
MASTER CHART 
 
 
 
  
 
                                       INTRODUCTION 
              Human immunodeficiency virus (HIV) is a member of the 
family Retroviridiae, a group of RNA viruses that possess an RNA 
dependent DNA polymerase known as reverse transcriptase. Three 
subfamilies of Retroviridiae has been reported namely Oncovirinae, 
Spumavirinae and Lentivirinae, of which HIV is related to lentivirinae.
1,2  
The epidemic of HIV associated disease has been first identified in 1981 
and in 1982 the term “AIDS” denoting ACQUIRED IMMUNE 
DEFICIENCY SYNDROME, the final manifestatiodn of HIV disease 
has been coined. In 1983, the etiologic agent was identified with the 
discovery of human T cell lymphotropic virus type III in United 
States.
1,3 
In India, HIV was first identified in 1986 in Chennai among 
commercial sex workers. At present the prevalence of HIV infected 
people in India is 2.5 million and in worldwide it’s about 65 million.
4,5 
The incidence of new HIV infections occurring globally each day is 
about 14,000 of which more than 95% are in developing countries. 
Eighty percent of the new HIV infections are due to heterosexual 
transmission and majority occurring in persons aged between 15 to 49 
years.
4,6
 
  
Ophthalmic manifestations are common in HIV infected patients 
occurring in more than 90% of autopsy cases in one series.
1
 The 
cumulative lifetime risk of developing at least one abnormal ocular 
lesion for a HIV positive person during the course of the disease is 
found to be between 52 to 100 % in various studies. Ocular lesions 
usually occur in the late phase of the disease but can also occur in the 
early stages also.
4,7
 The first case of AIDS with ocular lesions reported 
from India had CMV retinitis along with dementia.
8, 9 
Ocular 
manifestations may be the initial presentation of a systemic infection in 
an asymptomatic HIV positive patient.
8, 10
 Hence early detection of the 
manifestations is critical which has got an impact on the prognosis of the 
disease.
11,12
 The spectrum of HIV related ocular manifestation varies by 
geographic location and with opportunistic infection related eye diseases 
more common in South Asia compared to Sub Saharan Africa.
13,14
 
 
 
 
 
 
  
                                    REVIEW OF LITERATURE 
IMMUNOLOGY: 
                           There are two types of HIV i.e. Type1 and Type2. 
Type1 is more common. The subtypes of HIV-1which are more 
prevalent in India are A, B and C. The virus is 120 nm in diameter and 
consists of an outer envelope of glycoprotein, a core shell and a cone 
shaped inner core containing reverse transcriptase enzyme.
15 
                              Lymphocytes in blood are divided into T (thymus 
derived) and B (bone marrow derived) the former forming 65-80% and 
the latter forming 5 to 15% of peripheral blood lymphocyte. T cells are 
classified into CD4+ helper T cells and CD8+ cytotoxic T cells, the 
former are predominantly affected in HIV infected patients. CD4+ T 
cells are divided into two types according to their cytokine production.
16
 
HIV can destroy the CD4+ T cells by binding to both the CD4+ receptor 
and a co receptor (two types of co-receptors i.e. CCR-5 for macrophage 
tropic and fusin for T cell tropic) and integrating itself into the host 
DNA after conversion of viral RNA into double stranded DNA. Normal 
CD4+ counts are between 300 to 1000 cells/cu.mm. Functional defects 
in B lymphocytes occur in the early course of infection due to which 
  
deficient antibody response to new antigens occur despite 
hypergammaglobulinemia.
17
 
 
Correlation of CD4 cell count and HIV associated ocular 
disease.
17,18,19 
CD4 count 
(cells/cu.mm) 
Disease 
<500 up to 250 
• Kaposi sarcoma 
• Ocular tuberculosis 
<250 
• Pneumocystosis 
• Toxoplasmosis 
• Retinal/conjunctival micro 
vasculopathy 
<100 • Keratoconjunctivitis sicca 
<50 
• Intra ocular lymphoma 
• HIV associated uveitis 
• Cryptococcal choroiditis 
• Cidofovir & Rifabutin induced 
uveitis 
• Necrotizing herpetic retinitis (CMV, 
VZV) 
At any CD4 count 
• Herpes zoster keratouveitis 
• Molluscum contagiosum 
• Endogenous endophthalmitis  
  
Structure of HIV 
 
OCULAR MANIFESTATIONS OF HIV INFECTION - 
ETIOLOGY 
The ocular manifestations in HIV infected patients may result from the 
following.
17
 
1. The underlying infection itself – ex. HIV induced retinopathy 
2. Opportunistic infections –ex. CMV retinitis. 
3. Neoplasms due to impaired surveillance – ex. Intra ocular 
lymphoma. 
4. Complications arising from treatment – ex. Cidofovir induced 
uveitis. 
  
5. Altered immune regulation giving rise to autoimmune 
phenomenon – ex. Keratoconjunctivitis sicca. 
OPHTHALMIC DISORDERS ASSOCIATED WITH HIV INFECTION.
20,21
 
I. Non-infectious vasculopathy  
A. Microvasculopathy  
i. Retina -“HIV retinopathy” 
ii. Conjunctival microvasculopathy 
iii. Optic nerve 
B. Macrovasculopathy 
i. Retina  
a) Venous occlusions 
b) Arterial occlusions 
II. Infections  
A. Ocular surface and adnexa 
i. Molluscum contagiosum virus dermatitis, blepharitis 
ii. Herpes zoster ophthalmicus 
iii. Herpes simplex virus keratitis 
iv. Microsporidial Keratoconjunctivitis 
v. Bacterial and fungal keratitis 
B. Retina and choroid 
i. Cytomegalovirus retinitis  
  
ii. Varicella zoster virus retinitis 
iii. Herpes simplex virus retinitis 
iv. Syphilitic uveitis/retinitis 
v. Toxoplasma Gondi retinochoroiditis 
vi. Pneumocystis carinii choroidopathy  
vii. Mycobacterium tuberculosis choroiditis 
viii. Histoplamosis 
C. Orbital infections 
i. Preseptal cellulitis 
III. Neoplasms  
A. Eyelid/ocular surface  
i. Kaposi's sarcoma 
ii. Lymphoma 
iii. Squamous cell carcinoma 
B. Intraocular  
i. Lymphoma 
C. Orbit  
i. Lymphoma 
ii. Kaposi's sarcoma (rare) 
IV. Neuro-ophthalmologic abnormalities associated with intracranial 
or orbital diseases  
A. Infections  
  
i. Cryptococcal meningitis 
ii. Intracranial toxoplasmosis 
iii. Progressive multifocal leukoencephalopathy 
iv. Varicella-zoster virus infection 
v. Syphilitic meningitis 
vi. Tuberculosis meningitis 
B. Neoplasms  
i. Intracranial lymphoma 
V. Adverse effects of systemic drugs  
A. Uveitis  
i. Cidofovir 
ii. Fomivirsen 
iii. Rifabutin 
B. Optic neuropathy  
i. Ethambutol 
C. Retinopathy  
i. Didanosine 
VI. Auto immune phenomenon: 
A. Kerato conjunctivitis sicca 
  
ANTERIOR SEGEMENT AND ADNEXAL MANIFESTATIONS 
A. HERPES ZOSTER OPHTHALMICUS: 
              It is caused by varicella zoster virus (VZV) which on primary 
infection causes chickenpox and on reactivation causes zoster. Herpes 
zoster usually occurs in 10 to 20% of the infected individuals with VZV. 
The virus remains latent in the sensory neurons, of which mostly is 
detected in the trigeminal nerve. Upon its reactivation in the ophthalmic 
division of the trigeminal nerve herpes zoster ophthalmicus (HZO) 
occurs. In a study conducted by Hodge and associates, they found the 
individual risk of obtaining HZO in HIV infected persons is 6.6:1 
compared to non-infected persons.
13,7  
                   A study by Sellitti et al showed that HZO in HIV infected 
persons is of severe, long duration, more complications, increase in 
hospitalization and increases in rate of recurrence compared to non HIV 
infected persons.
13,22
 There has also been an increase in incidence of 
HZO in patients who are on HAART immediately after treatment with 
protease inhibitors, which was proved by Martinez and his 
associates.
13,23 
This was due to the immune recovery phenomenon. A 
case of herpes zoster ophthalmicus with orbital apex syndrome has been 
reported as an initial manifestation of HIV infection in a case report.
24
 
  
B. VIRAL KERATITIS: 
                The most common causes of infectious keratitis in HIV 
infected persons are VZV and herpes simplex virus (HSV).
25 
The 
incidence of VZV keratitis in individuals with HZO was found to be 
65%  and for dendritiform lesions it is about  51%.
13, 26  
Compared to non 
HIV infected persons, HIV infected persons are more likely to 
experience corneal involvement and at increased chances for 
perforation.
13,25  
In a study by Engstrom and Holland, they found that 
HIV infected persons will experience chronic keratitis due to VZV. 
Lesions in chronic VZV keratitis often become more pleomorphic with 
thickened opaque epithelium.
13,27
 Corneal stromal involvement has been 
seen rarely in HIV infected persons and this can be attributable to T cell 
dysfunction which may be protective against stromal keratitis.
13 
In a 
study done by Young and associates, they found the atypical 
presentation of epithelial keratitis in HIV infected persons which include 
marginal location, mean healing time of 3 weeks, relative resistance to 
treatment, lengthier recurrences.
13,27
 Patients with HZO on HAART may 
develop VZV stromal keratitis and it occurs due to immune recovery.  In 
a case report by Naseri and Margolis, a patient with resolved HZO 
developed stromal keratitis on HAART as T cells presumably 
  
recognized and responded to VZV antigens in the corneal stroma and 
cause stromal keratitis.
13,28
 
                 CMV (cytomegalo virus) can cause both epithelial and 
stromal keratitis, but both being very rarely seen even though CMV is 
the most common opportunistic infectious agent among HIV infected 
patients.
13,29 
The incidence of corneal endothelial deposits among found 
patients with CMV retinitis is about 80%.
13,30
 These are mostly seen in 
the inferior cornea in linear, stellate, reticulate pattern and are composed 
of fibrin and macrophages.
13 
C. BACTERIAL KERATITIS: 
                    Despite the presence of normal ocular flora, the risk of 
infections with normal flora itself is great in HIV infected patients.
13
 
Pseudomonas aeruginosa, Staphylococcus aureus and Staphylococcus 
epidermidis are more commonly found in HIV infected persons.
13,31
 The 
factors responsible for these infections for presence of concomitant dry 
eye and healed viral keratitis which causes epithelial defect and pave 
way for the normal flora.
13 
Their clinical significance being they are 
more bilateral, multi pathogenic and more prone for perforation.
13,32
 Low 
level of inflammation plays a role in delay in treatment.
13
 In case of 
  
coinfection with Neisseria gonorrhea, HIV can modify the host response 
resulting in more severe clinical features.
13,33 
D. FUNGAL KERATITIS: 
                In contrast to normal population where history of trauma 
plays as a predisposing factor to fungal corneal ulcer, it develops 
spontaneously in HIV infected persons. Candida and Cryptococcus 
are the common causes. Cryptococcus commonly causes meningitis 
and choroiditis but cases of iris granuloma, scleral perforation have 
also been noted.
13,34 
In HIV infected persons they run a more 
protracted course, often bilateral and can lead to corneal 
perforation.
35
 Polymicrobial keratitis has been reported as an initial 
manifestation of HIV infection. In a case report by Radhika et al, in 
which they reported a case of spontaneous ulcerative keratitis caused 
by coagulase negative Staphylococcus, Fusarium and Acanthamoeba 
in a same patient.
36
 
E. MICROSPORIDIAL KERATITIS: 
                         Microsporidia are spore forming, obligate, intracellular 
parasites. Microsporidial keratitis should be suspected in HIV infected 
persons in whom repeated culture for epithelial keratitis comes as 
negative.
13 
It is typically characterized by bilateral superficial punctate 
keratitis, intra epithelial white infiltrates, mild anterior chamber reaction 
  
and follicular hypertrophy.
13,37 
They typically cause systemic 
manifestations when the CD4 count fall below 100 cells per cu.mm.
13
 
F. MOLLUSCUM CONTAGIOSUM: 
                         It is seen in 5% of HIV infected patients, caused by a 
pox virus and has an incubation period of 6 to 8 weeks.
13 
It is 
characterized by pink or pearly white nodules on the skin. The major 
clinical significance in HIV infected persons is that Mollusca occurs as 
larger in number and size over lids and conjunctiva, confluent, more 
resistant to therapy with more chances of recurrence. A chin-strap 
distribution is more common in HIV infected patients.
13
It has been 
reported as the initial manifestation of HIV infection.
13
 
G. TOXOPLASMIC UVEITIS: 
                           In HIV infected persons a primary anterior uveitis can 
occur even without the presence of retinal lesions, though in immune 
competent persons it can occur only as a secondary phenomenon.
13,38
 
Severe anterior segment inflammation with iris nodules and destruction 
has been noted
13 
  
H. ANTERIOR UVEITIS: 
                            Anterior uveitis as an isolated symptomatic disorder is 
very rare in HIV infected persons.  In a study conducted by Verma et al, 
it was concluded that anterior uveitis not very symptomatic in HIV 
infected patients. They followed a group of 172 HIV positive patients, 
among whom only 12 patients had symptomatic anterior uveitis.
39 
Mild 
iridocyclitis in HIV infected persons is commonly due to posterior 
segment disease most common being CMV retinitis as demonstrated by 
Cunningham and Margolis.
40 
I. SYPHILITIC UVEITIS: 
                        It is the most common cause of bacterial uveitis in HIV 
infected patients and its prevalence was found to be about 0.6%. The 
clinical significance in HIV infected persons is that it causes pan uveitis 
with more severe anterior segment inflammation.
13
 As compared to 
immune competent hosts, ocular syphilis in HIV positive persons has a 
more protracted course and severe clinical features.
13   
Other 
manifestations being chancres of conjunctiva, gumma and conjunctivitis 
with the latter being histologically similar to sarcoidosis.
13 
  
MYCOBACTERIUM RELATED ANTERIOR SEGMENT 
DISORDERS: 
                   There is no change in type of anterior segment lesions 
caused by TB in HIV infected and non-infected people. Common 
presentations include granular masses, polypoid tumours, ulcers, 
granulomatous uveitis and chronic red eye.
13,41 
It can also present as 
interstitial keratitis, nodular scleritis, and sclerokeratitis. 
J. ADNEXAL INFECTIONS: 
                   Preseptal cellulitis due to staphylococci has been found in 
HIV infected persons due to the presence of twice the number of 
staphylococci in nasal mucosa compared to normal individuals.
13 
Lid 
abscesses due to staphylococci, CMV in association with Molluscum 
contagiosum has also been found in HIV infected persons. Blepharitis is 
more common and has been reported as an initial manifestation of HIV 
infection along with lid ulcer in a case report.
42
 
K. CONJUNCTIVAL MICROVASCULOPATHY: 
Almost 3/4
th
 of HIV infected persons have some form of 
conjunctival microvasculopathy which include: 
1. Segmental narrowing and dilatation  
  
2. Visible granularity in the blood column 
3. Comma shaped granular fragment  
4. Micro aneurysm formation.
13
 
These changes have more correlation with the occurrence of HIV 
retinopathy and more commonly occur in the inferior limbus area. The 
exact etiology is still unknown and it may be due to immune complex 
deposition, increased viscosity of the blood or due to direct effects of the 
virus itself.
13 
L. KERATOCONJUNCTIVITIS SICCA:
 
It occurs in the later stage of the disease and in about 20 to 30% of 
affected individuals. The etiology is due to inflammatory destruction of 
the main and accessory lacrimal glands due to lymphocytic infiltration 
and direct damage of the conjunctival surface by the virus itself.
13
 
It predisposes to secondary bacterial keratitis due to epithelial defects 
and spontaneous corneal thinning with perforation can also occur due to 
the virus itself.
13
 
A case of keratomalacia with Xerophthalmia has been reported as an 
initial manifestation of HIV infection in a case report by Cynthia et al.
43 
Vitamin A deficiency even though rare in adults can manifest commonly 
in HIV infected individuals. 
  
M. NEOPLASMS OF THE ADNEXA: 
In the western world Kaposi’s sarcoma is the most common adnexal 
neoplasm associated with HIV, whereas in India it is uncommon due to 
the low prevalence of human T cell lymphotropic virus (HHV 8).
 
In the 
African countries it’s the squamous cell carcinoma of conjunctiva which 
is more common. Kaposi’s sarcoma has been included as one of the 
presentation in diagnosing AIDS defining illness. 
1. KAPOSI’S SARCOMA: 
Kaposi’s sarcoma is a vascular mesenchymal tumor appearing as red 
velvet nodules on the ocular surface. It occurs mostly in the inferior 
fornix and histologically shows incomplete vascular spaces without 
endothelium surrounded by malignant spindle cells which are of 
endothelial origin.
44
 The classification of adnexal Kaposi’s sarcoma has 
been given by Dugel and his colleagues who divided it into three types. 
Type 1and 2 lesions are patchy, flat, less than four months of 
duration and less than 3 mm in height, whereas type 3 lesions are more 
than four months duration and more than 3 mm in height.
 
Conjunctival 
Kaposi’s sarcoma may mimic sub conjunctival hemorrhage or as an 
elevated purple red mass, whereas Kaposi’s sarcoma on eyelids may 
mimic like other lesions elsewhere in the body. 
  
2. SQUAMOUS CELL CARCINOMA: 
Most common presentations of squamous cell carcinoma include
13
 
 Nasal location  
  Faster growth  
 Size greater than 1 cm 
 Changes in color 
 Corneal over riding. 
  In a study done by Chisi et al the estimated prevalence of 
squamous cell carcinoma in HIV positive patients is 7.8%. He evaluated 
409 HIV positive patients between 25 to 53 years and detected 103 
patients with conjunctival growths, of whom 32 had histologically 
proven squamous cell carcinoma.
45 
HIV testing, should be carried out in 
all patients with squamous cell carcinoma who live in high risk areas as 
it may be the first sign of HIV positivity. 
3. NON HODGKIN’S LYMPHOMA: 
Non-Hodgkin’s lymphoma tends to be of higher grade and occur in 
5% of HIV positive patients. NHL can mimic as kerato conjunctivitis 
sicca and anterior chamber reactions can occur with intra ocular 
lymphoma. Primary NHL can present as proptosis, ptosis, gaze paresis, 
internal ophthalmoplegia.
46 
  
N. IMMUNE RECOVERY UVEITIS: 
Immune recovery uveitis is a phenomenon noted as a part of immune 
reconstitution syndrome (IRIS) occurring in patients on HAART. 
Before the introduction of HAART people with CMV retinitis had CD4 
count less than 50/cu.mm and minimal intra ocular inflammation. 
Immune recovery uveitis mainly involves the anterior uvea and vitreous 
and is associated with marked disturbance of visual function and more 
inflammation. It occurs as a phenomenon to old CMV antigens on their 
path to immune recovery, hence it is more important to recognize this 
condition among people on HAART.
47 
O. DRUG INDUCED UVEITIS: 
A predominantly anterior uveitis occurs as a toxic effect of Rifabutin 
and Cidofovir with discrepancy between morphological changes and 
clinical symptoms.
48 
Rifabutin is used as a prophylactic agent and as an 
anti-mycobacterial agent, while Cidofovir is used for CMV and other 
group of herpes viruses. The incidence of Rifabutin induce uveitis is less 
than 0.01% when used at a dosage of 300 mg/day and its incidence is 
increased when used at the rate of more than 450 mg/day.
49
 The 
incidence of Cidofovir induced uveitis is high when the intravitreal dose 
is greater than 40 µg, whereas the incidence is low when the intravitreal 
  
dose is less than 20 µg. The incidence of Cidofovir induced uveitis is 
more when it is used concomitantly with protease inhibitors due to 
potential drug interactions.
50 
POSTERIOR SEGMENT MANIFESTATIONS:
 
Posterior segment manifestations are more common in HIV infected 
persons than other manifestations.
51
 The spectrum of manifestations 
varies demographically with opportunistic infections related 
manifestations common in developed countries than in developing 
countries.
 
A. HIV RETINOPATHY(MICRO VASCULOPATHY): 
It is the most common ocular manifestation seen in about 60% of 
HIV infected persons.
52
 It is characterized by the presence of cotton 
wool spots which are located more around the posterior pole. 
They represent infarct in the nerve fiber layer and consist of 
yellowish patches with more rounded borders found along the vascular 
arcade in the posterior pole with no associated hemorrhages or areas of 
necrosis. Most patients are asymptomatic and severity varies according 
to the location of lesion. The occurrence of HIV retinopathy is inversely 
related to the CD4 Count.
 
  
B. MACRO VASULOPATHY:
51
 
Large vessel occlusions though very rare can occur in association 
with necrotizing retinitis, infiltrative lymphomatous optic neuropathy 
and as an isolated disorder.
 
A case of central retinal vein occlusion due 
to herpetic necrotizing retinitis has been reported as the initial 
manifestation of HIV infection in a case report.
53
 
C. OPPORTUNISTIC INFECTIONS:
51
 
Opportunistic infections of the posterior segment can occur as a 
unifocal or multifocal choroiditis but more commonly as a necrotizing 
retinitis. 
Retinitis in inflamed eyes usually occur with higher CD4 counts and 
are commonly due to acute retinal necrosis(ARN), syphilis, 
Cryptococcus and toxoplasmosis, whereas retinitis in quiet eyes is 
commonly due to CMV and progressive retinal necrosis. (PRN) 
1) CYTOMEGALO VIRUS RETINITIS:
20
 
  CMV retinitis is by far the most common opportunistic intraocular 
infection in people with AIDS. In a study done by Lim et al, who 
reviewed the spectrum of ophthalmic manifestations of 118 HIV positive 
individuals in Singapore between May 1995 to October 1996 and found 
  
that CMV retinitis was the most common cause of visual loss found in 
37 patients.
54 
CMV retinitis is rarely the first manifestation of AIDS as it 
occurs mostly in patients who haveCD4+ T-lymphocyte counts of less 
than 50 cells/cu.mm at diagnosis. One study found that 85% of people 
with extra ocular CMV infection developed CMV retinitis after a mean 
follow-up period of 6.4 months.
 
Heterosexual men are less likely than 
homosexual men to develop CMV retinitis, perhaps because 
homosexuals have a higher rate of pre-existing CMV infection.
 
CMV 
retinitis remains a major cause of morbidity in HIV-infected people. 
CMV retinitis may begin with infection of retinal vascular endothelial 
cells, with subsequent spread to adjacent glial and neuronal cells as well 
as to RPE, although early autopsy studies failed to identify infected 
endothelium in all cases.
 
The diagnosis of CMV retinitis is based on 
clinical signs and symptoms with most patients being asymptomatic if it 
is unilateral. One study found that over half of new cases of CMV 
retinitis were diagnosed during routine screening eye clinic visits and 
that over 75% of affected patients were asymptomatic at the time of 
diagnosis. Hence routine screening has been recommended every 3 
months in patients with CD4 count less than 50/cu.mm.
55
  
There are three clinical forms – classical, indolent, frosted branch 
angitis.
56 
The classical form is characterized by areas of confluent 
  
necrosis with hemorrhage that develops along the vascular arcade giving 
rise to a “pizza pie” or “cottage cheese” appearance. The advancing 
edges of the lesions spread contiguously and very sharp which untreated 
gives rise to full thickness gliosis and atrophy. The indolent form is 
noted as a granular lesion in the peripheral retina and has less dense 
opacification without any hemorrhage. Bilateral involvement occurs in 
30% to 40% of cases at diagnosis. There are usually mild anterior 
chamber and vitreous inflammatory reactions, and fine keratic 
precipitates are often seen.  
The natural history of CMV retinitis is progressive with eventual 
destruction of the entire retina occurs within 6 months.
  
Untreated lesions 
enlarge slowly; spread toward the fovea occurs at a median rate of only 
24 µm/day or approximately 750 µm every three weeks and is somewhat 
faster toward the ora serrata.
 57 
Rhegmatogenous retinal detachment is 
more common with CMV retinitis, occurring in 13 to 29% of patients 
and can occur either in active or healed phase of the disease. The risk of 
occurrence of retinal detachment and immune recovery uveitis is directly 
proportional to the area of involvement of CMV retinitis. 
 
 
  
2) NECROTISING HERPETIC RETINITIS: 
It is a spectrum of retinitis induced by herpes viruses most 
commonly by VZV. It includes two types – 
1. Acute retinal necrosis (ARN)  
2. Progressive retinal necrosis (PRN). 
 
1. ACUTE RETINAL NECROSIS:
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  It is a devastating necrotizing retinitis which affects males more 
than females in the ratio 2:1 and is biphasic disease, tends to be caused 
by HSV in younger individuals and by VZV in older individuals. 
Presentation is usually unilateral with vitritis and granulomatous anterior 
uveitis being found in almost all cases. Retinitis includes peripheral 
retinal periarteritis associated with multifocal deep yellow white retinal 
infiltrates. Gradual coalescence of infiltrates with full thickness necrosis 
and circumferential progression occurs. The posterior pole is usually 
spared till late. Acute lesions resolve within 6 to 12 weeks leaving 
transparent necrotic retina with hyper pigmented borders. The second 
eye is involved in 30% usually within 2 months unless treated. Prognosis 
is relatively poor particularly with VZV with 60% of patients having a 
  
final visual acuity less than 6/60 due to retinal detachment, ischemic 
optic neuropathy and occlusive periphlebits.
95
 
2. PROGRESSIVE RETINAL NECROSIS:
57
 
It is caused by VZV and behaves aggressively as a consequence of 
profound immune suppression. Presentation is with rapidly progressive 
visual loss which is usually unilateral and characterized by minimal 
anterior uveitis and vitritis, yellow white retinal infiltrates, rapid 
confluence and full thickness retinal necrosis with early involvement of 
macula. Vitreous inflammation is usually late and reflects extensive 
retinal necrosis. 
D. TOXOPLASMOSIS: 
In HIV infected persons, toxoplasmosis occurs as a primary infection 
rather than reactivation. In contrast to immune competent persons, it is 
usually multi focal, bilateral and rarely associated with chorioretinal 
scars. It may cause other abnormalities like vitritis, iritis, papillitis, retro 
bulbar neuritis and outer retinal toxoplasmosis.
58
 In contrast to CMV 
retinitis it is associated with more severe intra ocular inflammation and 
less hemorrhages. 
  
E. CHOROIDITIS: 
1) TUBERCULOSIS:
51
 
Choroiditis associated with tuberculosis can present either as 
multifocal choroidal tubercles with discrete yellow lesions at the 
posterior pole or it can present as a solitary posterior pole granuloma 
like mass lesion. Though pulmonary tuberculosis is commonest systemic 
opportunistic infection in India, the incidence of ocular tuberculosis 
among HIV infected persons is very low. In a study conducted by Alay 
banker et al, in 1286 cases of HIV infected persons the incidence of 
ocular tuberculosis is found to be 1%.
58 
2) CRYPTOCOCCAL CHOROIDITIS: 
  It can be solitary or confluent, multifocal and may be associated 
with granulomatous iritis, iris mass, necrotizing retinitis, 
endophthalmitis, conjunctival mass, eyelid nodule and optic neuritis.
51
 
Meningitis associated with Cryptococcus is the most common cause of 
Neuro ophthalmic manifestation of HIV associated ocular disease. 
3) PNEUMOCYSTIS CHOROIDITIS:
57
 
  Pneumocystis jiroveci is the major cause of mortality and 
morbidity in AIDS. The presence of choroidal involvement can be an 
important feature of extra pulmonary systemic dissemination. 
  
Presentation includes flat, yellow, round choroidal lesions scattered 
throughout the posterior pole which are frequently bilateral and not 
associated with vitritis. The lesions may coalesce and produce large 
geographic patches. Even when the fovea is involved the visual 
impairment is little.
 
                  4) MALIGNANCY INDUCED CHOROIDITIS:
 
Non-Hodgkin’s lymphoma can produce necrotizing retinitis, 
multifocal choroiditis, retinal vasculitis, vitritis, sub retinal mass and 
pseudo hypopyon uveitis.
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                  5) SYPHILIS: 
Ocular syphilis may present as iritis, vitritis, retro bulbar optic 
neuritis, papillitis, retinal vasculitis, necrotizing retinitis which may be 
clinically indistinguishable from CMV and exudative retinal 
detachment.
60 
NEURO OPHTHALMOLOGICAL MANIFESTATIONS:
61 
The incidence of nervous system involvement is about 50% in HIV 
infected persons resulting in different patterns of neurological 
involvement at some point during the course of the disease. The 
incidence of Neuro ophthalmological disorders is about 3 to 8%.
62 
The 
  
various Neuro ophthalmological manifestations include optic neuropathy 
which may be Neuro retinitis, anterior optic neuropathy or retro bulbar 
neuritis, abnormal movement of saccades or pursuits, ocular motor 
palsy, gaze palsy, visual field defects, papilledema, optic atrophy, 
cortical blindness. The causes include cerebral toxoplasmosis, 
Cryptococcal meningitis, tuberculous meningitis, AIDS related dementia 
complex, cerebral lymphoma and herpes zoster encephalitis. Sometimes 
these may be the presenting feature of otherwise asymptomatic HIV 
infected person. A case of isolated homonymous hemianopia due to 
presumptive cerebral tuberculosis has been manifested as an initial 
presentation of HIV infection in a case report by Sujit gharai et al.
63 
I. OCULAR MOVEMENT DISORDER: 
  In a study done by Sweeney et al, they found that seropositive 
patients demonstrated disturbances in pursuit movements that were 
correlated with the extent of immunosuppression. They noted that 
oculomotor disturbances are present in HIV positive individuals even 
before they develop manifestations of marked AIDS dementia complex. 
Due to this, they suggested quantitative eye movement studies may 
provide a useful Neuro behavioral procedure for characterizing and 
monitoring the progression of CNS involvement associated with HIV 
  
infection from early in its course. In asymptomatic patients they 
represent the early manifestation of HIV infection.
64
 
II. OPTIC NEUROPATHIES: 
Optic neuropathies in HIV infected persons can occur due to 
infectious, compressive and inflammatory etiologies. Recent evidence 
support HIV by itself can produce optic neuropathy. Optic nerves of 
HIV infected persons can undergo chronic degeneration resulting in 
axonal loss. In a study by Sadun et al, they found that axonal 
degeneration was noted in association with mononuclear cell infiltration 
in sections of optic nerve of HIV positive individuals suggesting the role 
of HIV itself in the pathogenesis of primary optic neuropathy.
65
  Current 
theories emphasize the importance of tumor necrosis factor alpha in the 
evolution of primary HIV optic neuropathy.
 
III. CRANIAL NERVE PALSY: 
In a study conducted by Mwanza et al, the prevalence of cranial 
nerve palsy is 25%. The most common nerves to be involved are sixth 
and third. Even though toxoplasmosis and cryptococcosis are the most 
common causes, the exact cause is complicated by the presence of 
multiple underlying etiologies.
66
 
  
IV. ABNORMALTIES IN VISUAL EVOKED POTENTIAL: 
The incidence of subclinical abnormal VEPs (Visual evoked 
potential) has been reported to be around 3 to 49% in HIV infected 
persons. Though completely normal VEPs have been found in both 
neurologically symptomatic and asymptomatic individuals.
67 
There are 
evidence that, despite normal visual acuity HIV infected persons may 
have subclinical dysfunction of the visual pathways which can be 
detected using electro physiological methods.
68 
 
 
 
  
OBJECTIVES OF THE STUDY: 
1. To determine the ocular manifestations of HIV infection occurring 
in adults at the time of diagnosis. 
2. To estimate the prevalence of ocular manifestations occurring at 
the time of diagnosis. 
3. To determine visual impairment associated with HIV related 
ocular manifestations. 
4. To correlate the ocular manifestations with the demographic 
profile and clinical stage of the disease at the time of diagnosis. 
 
 
 
 
 
 
 
  
MATERIALS AND METHODS: 
STUDY DESIGN: 
 It is a hospital based cross sectional study. 
STUDY PERIOD: 
The study was done between the periods from September 1, 2011 
to September 1, 2012. 
STUDY POPULATION: 
The study was done among people who attended the Outpatient 
clinic of Department of sexually transmitted diseases (STD) and ART 
Centre, who are newly diagnosed as seropositive for HIV. 
STUDY METHODS: 
          Before commencing the study, Ethics committee approval was 
obtained from the Ethics committee of Coimbatore medical college 
and government hospital. Patients were screened at outpatient clinic 
twice in a week for newly detected seropositivity for HIV. After they 
underwent counseling, they were explained about the ocular 
manifestations which may occur during the course of the disease and 
the need for ophthalmic screening. After obtaining clear consent (oral 
  
consent was used in the present study) the patients were enrolled for 
the study. For maintaining the confidentiality of the patient, names of 
the patient were neither disclosed any other person nor published in 
any written form. Even the registration number in the ART clinic 
which is unique to each patient was neither disclosed nor published. 
Instead the outpatient number of OP clinic of ophthalmology was 
used as the reference number. The inclusion and exclusion criteria 
used were as follows: 
INCLUSION CRITERIA: 
1. Age  > 19 Years and < 65 years, 
2. Newly diagnosed patients of HIV seropositivity, with blood 
investigation confirmed at VCTC, CMCH. 
3. Patients diagnosed as HIV positive outside centres who came to 
attend ART centre are also included 
4. Patients who are referred from other department to VCTC centre 
for screening purposes. 
EXCLUSION CRITERIA: 
1. Children and < 19 years. 
2. Pregnant women 
3. Persons who are terminally ill. 
  
4. Persons who are unable to give consent due to Neuro behavioral 
problems. 
5. Persons who are not willing for giving consent because of 
confidentiality loss. 
After making sure the patient falls under the above criteria, patients 
were brought to the OP clinic of Ophthalmology department and 
registered. They were undertaken for the following protocol 
1. A thorough history taking was taken – first regarding the 
demographic profile of the patient including  
- Age 
- Occupation 
- Income 
- Marital status 
- Sexual history 
- Associated history of tuberculosis 
- Drug abuse/blood transfusion 
2. Patients were asked about the presence or absence of ocular 
symptoms. 
3. The socio economic status of the patient was found by using 
modified Kuppuswamy grading scale. 
  
4. Presence or absence of systemic symptoms was asked and clinical 
stage of HIV was determined using WHO grading of clinical stage 
of HIV disease. 
5. CD4 count value which was determined at the time of diagnosis 
was noted. 
6. The patient was then subjected to a routine ophthalmic 
examination which includes the following: 
- Best corrected visual acuity was determined using 
Snellen’s chart. 
- Any evidence of previous refractive error was also 
noted. 
- A central  field charting was done using Bjerrum  screen 
- A simple torch light examination was performed to look 
at the lids and adnexa. 
- A slit lamp examination was done to determine the 
anterior segment. 
- A Schirmer’s test to determine the tear film status was 
done 
- After dilatation with 1% Tropicamide a detailed fundus 
examination was done using direct ophthalmoscope, 
90D lens attached with slit lamp and an indirect 
ophthalmoscope. 
  
7. All findings were noted and the final ophthalmic status was noted. 
8. In case of getting abnormal findings, it was examined and 
confirmed by another person. In this study it was done by the 
guide of the study. 
9. To avoid bias, above things were done only by the principal 
investigator alone. 
10. The ophthalmic status was revealed to the patient after necessary 
counseling and need for periodic review was suggested. 
11. Since the study was a cross sectional study (single time study) 
reviews of the patients were not conducted exclusively by the 
investigator to avoid bias. The enrollment of the patient under the 
study was not revealed to others. 
12. At the end of the study period the data were given to an 
investigator for statistical analysis. 
 
 
 
 
 
 
  
 
WHO CLINICAL STAGING OF HIV/AIDS FOR ADULTS AND 
ADOLESCENTS WITH CONFIRMED HIV INFECTION
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Clinical stage 1 
• Persistent generalized lymphadenopathy 
• Asymptomatic 
Clinical stage 2 
• Recurrent respiratory tract infections  
• Moderate unexplained weight loss  <10% of presumed or measured 
body weight 
• Herpes zoster 
• Recurrent oral ulceration 
• Angular cheilitis 
• Papular pruritic eruptions 
• Seborrhoeic dermatitis 
• Fungal nail infections 
Clinical stage 3 
• Unexplained persistent fever (above 37.6°C intermittent or 
constant, for longer than one month) 
• Unexplained chronic diarrhea for longer than one month 
  
• Unexplained severe weight loss (>10% of presumed or measured 
body weight) 
• Persistent oral candidiasis 
• Oral hairy leukoplakia 
• Pulmonary tuberculosis (current) 
• Severe bacterial infections (such as pneumonia, empyema, 
pyomyositis, Bone or joint infection, meningitis or bacteremia) 
• Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis 
• Unexplained anemia, neutropenia Or chronic thrombocytopenia . 
Clinical stage 4 
• HIV wasting syndrome 
• Pneumocystis pneumonia 
• Recurrent severe bacterial pneumonia 
• Chronic herpes simplex infection (orolabial, genital of more than 
one month’s duration or visceral at any site) 
• Esophageal candidiasis (or candidiasis of trachea, bronchi or 
lungs) 
• Extra pulmonary tuberculosis 
• Kaposi’s sarcoma 
• Cytomegalovirus infection (retinitis or infection of other organs) 
• Central nervous system toxoplasmosis 
  
• HIV encephalopathy 
• Extra pulmonary Cryptococcosis including meningitis 
• Disseminated non-tuberculous mycobacterial infection 
• Progressive multifocal leukoencephalopathy 
• Chronic cryptosporidiosis (with diarrhea) 
• Chronic Isosporiasis 
• Disseminated mycosis (Coccidiomycosis or Histoplamosis) 
• Recurrent non-typhoidal Salmonella bacteremia 
• Lymphoma (cerebral or B-cell non-Hodgkin) or other solid HIV-
associated tumors. 
• Atypical disseminated leishmaniasis 
• Symptomatic HIV-associated nephropathy or symptomatic HIV-
associated cardiomyopathy. 
• Invasive cervical carcinoma 
MODIFIED KUPPUSWAMY GRADING OF SOCIO ECONOMIC 
STATUS:
 
It consists of three variables 
1. Profession 
2. Per capita income 
3. Occupation 
  
Each variable is given a score depending on the data. Finally all 
three are added to give a cumulative variable, which is categorized 
according to the score. 
Education Score 
Professional 7 
Graduate 6 
Intermediate 5 
High school 4 
Middle school 3 
Primary 2 
Illiterate 1 
 
Occupation Score 
Professional 10 
Semiprofessional 7 
Clerical, shop owner, farmer 5 
skilled 4 
Semi-skilled 3 
unskilled 2 
unemployed 1 
          
 
  
  
Family income per month Score 
>17520 12 
8760-17515 10 
6570-8750 6 
4380-6560 4 
2628-4370 3 
885-262 2 
<87 1 
 
 
Total score Socio economic status 
26 to 29 Upper I 
16 to 25 Upper middle II 
11 to 15 Lower middle III 
5 to 10 Upper lower I V 
< 5 Lower V 
 
 
 
 
 
  
STATISTICAL ANALYSIS: 
• NUMBER OF PERSONS ENROLLED FOR THE STUDY: 76 
• NUMBER OF EYES EXAMINED    : 152 
GENDER: 
• NUMBER OF MALES:   53 
• NUMBER OF FEMALES:   23 
                 
            
     
 
 
 
 
 
 
 
 
 
 
 
  
GENDER 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Males 34 19 53(69.7%) 
Females 12 11 23(30.3%) 
 46(60.5%) 30(39.5%) 76 
 
The Chi-square value of the above chart is 0.963 and the ‘P’ value is 
0.326 
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SOCIO ECONOMIC STATUS: 
                        CLASS 1:  0 
                        CLASS 2:  0 
                        CLASS 3:  27 
                        CLASS 4:  49 
                        CLASS 5:  0              
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Socio economic 
status 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
III 16 11 27 
IV 30 19 49 
Total 46 30 76 
 
  The Chi-square value for the above chart is 0.028 and the “P” value is 
0.867 
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AGE GROUPS: 
o LESS THAN   30:  15 
o 31 TO 40:   27 
o 41 TO 50:   22 
o 51 TO 60:   11 
o 60 AND ABOVE:    1 
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Age group 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
< 30 years 7 8 15 
31 – 40 years 18 9 27 
41 – 50 years 15 7 22 
51 – 60 years 6 5 11 
 60 years 0 1 1 
Total 46 30 76 
 
 
The Chi-square value for the above table is 3.870 and “P” value is 0.424  
 
 
 
  
MARITAL STATUS: 
o MARRIED        :   68 
o UNMARRIED   :     5 
o WIDOW            :     3 
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89%
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Marital status
 
 
 
 
 
  
 
 
Marital status 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Married 41 27 68 
Unmarried 4 1 5 
Widowed 1 2 3 
Total 46 30 76 
 
 
 
The Chi-square value for the above chart is 1.724 and the “P” value is 
0.422.  
 
 
 
 
  
MODE OF TRANSMISSION: 
o HETEROSEXUAL: 63 
o HOMOSEXUAL:  3 
o IV DRUG ABUSE: 0 
o BLOOD TRANSFUSION:  10 ( 10 Patients had history of 
both blood transfusion and sexual promiscuity) 
 
 
 
 
 
 
  
Mode of transmission 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Heterosexual 45 28 73 
Homosexual 1 2 3 
IV drug abuse 0 0 0 
Blood transfusion 6 4 10 
 52 34 86 
 
The chi-square value for the above test is 0.967 and the “P” value is 0.326 
 
 
 
 
 
 
  
HISTORY OF TUBERCULOSIS: 
• YES: 4 
• NO: 72 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
History of 
Tuberculosis 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Absent 45 27 72 
Present 1 3 4 
Total 46 30 76 
 
The chi-square value for the above table is   2.230   and the “P” value is 
0.135 
 
 
 
 
  
 
 
 
 
  
CLINICAL STAGE OF THE DISEASE: 
o Stage I:  52 
o Stage II:  21 
o Stage III:  0 
o Stage IV:  3 
 
 
 
 
 
 
 
 
 
 
 
 
  
Clinical stage of the 
disease 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Stage I 35 17 52 
Stage II 11 10 21 
Stage III 
 
0 0 0 
Stage IV 0 3 3 
Total 46 30 76 
 
 
The chi-square value for the above table is 6.184   and the “P” value is 
0.045 
 
 
  
CD4+ COUNT: 
• <50:     2 
• 51 TO 100:     7 
• 101 TO 150:     9 
• 151 TO 200:     3 
• 201 TO 250:     8 
• >250:   47  
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CD4 count 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
< 50 1 1 2 
51 - 100 3 4 7 
101 - 150 6 3 9 
151 - 200 3 0 3 
201 - 250 3 5 8 
 250 30 17 47 
Total 46 30 76 
 
 
The chi-square value for the above table is   5.096   and the “P” value is 
0.404   
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HISTORY OF OCULAR SYMPTOMS: 
• YES: 21 
• NO: 55  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Presence of 
ocular 
symptoms 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Yes 6 15 21 
No 40 15 55 
Total 46 30 76 
 
 
 
The chi-square value for the above table is 12.404   and the “P” value is 
0.000 
 
 
  
TYPES OF OCULAR SYMPTOMS:  
• DEFECTIVE VISION: 7 
• REDNESS: 11 
• IRRITATION & FB SENSATION:  6 
• PHOTOPHOBIA:  7 
•  FLOATERS:   0 
• OTHERS:  7  
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Ocular symptoms 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Nil 40 15 55 
Defective vision 2 5 7 
Redness 3 3 6 
Irritation & FB       
Sensation 
0 4 4 
Photophobia 0 2 2 
Floaters 0 0 0 
Others 1 1 2 
Total 46 30 76 
 
The chi-square value for the above table is 18.082   and the “P” value is 
0.012 
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VISUAL ACUITY – BOTH EYES: 
• NORMAL (6/6 – 6/18 in the better eye) :65 
• VISUAL IMPAIRMENT(<6/18 – 6/60 in better eye):  - 10 
• SEVERE VISUAL IMPAIRMENT(<6/60 – 3/60 in the better eye) – 1 
• BLIND (<3/60 in the better eye)– NIL 
 
 
  
 
 
 
 
 
 
  
Visual acuity – 
both eyes 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Normal 
6/6 – 6/18 in the 
better eye 
40 25 65 
Visual impairment 
<6/18 – 6/60 in the 
better eye 
5 5 10 
Severe visual 
impairment <6/60 
– 3/60 in the better 
eye 
1 0 1 
Blind <3/60 – 1/60 
in the better eye 
0 0 0 
Blind <1/60 – NO 
PL 
0 0 0 
Total 46 30 76 
 
The chi-square value for the above table is 1.144 and the “p” value is 
0.464   
 
 
 
 
 
 
 
 
  
VISUAL ACUITY - RIGHT EYE: 
 
• 6/6 – 6/18:  67 
• < 6/18 – 6/60:  8 
• < 6/60 – 3/60:   1 
• < 3/60 – 1/60:    0 
• <1/60 – NO PL:    0 
 
 
 
 
 
 
 
  
 
 
 
Visual acuity –   
Right eye 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
6/6 – 6/18 39 28 67 
<6/18 – 6/60 6 2 8 
<6/60 – 3/60 0 1 1 
<3/60 – 1/60 0 0 0 
<1/60 – NO PL 0 0 0 
TOTAL 46 30 76 
 
 
The chi-square value for the above chart is 1.504 and the “P” Value is 
0.471 
 
 
 
  
VISUAL ACUITY - LEFT EYE: 
• 6/6 – 6/18:   64 
• <6/18 – 6/60:    6 
• <6/60 – 3/60:     1 
• <3/60 – 1/60:     2 
• <1/60 – NO PL:     3 
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Visual acuity – 
left eye 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
6/6 – 6/18 38 26 64 
<6/18 – 6/60 4 2 6 
<6/60 – 3/60 1 0 1 
<3/60 – 1/60 0 2 2 
<1/60 – NO PL 0 3 3 
Total 46 30 76 
 
 
The chi-square value for the above table is 5.108 and the “P” value is 
0.276 
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 LIDS AND ADNEXA: 
• NORMAL     : 56 
• ABNORMAL: 20 
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Lids and adnexa 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Normal 38 18 56 
Abnormal 8 12 20 
Total 46 30 76 
 
 
The chi-square value for the above table is 4.787 and the “P” value is 
0.029 
 
 
 
  
  
FINDINGS IN LIDS AND ADNEXA:  
• Normal : 56 
• Herpetic lesions on lids: 3 
• Circum corneal congestion: 8 
• Raised lesion in conjunctiva: 4 
• Others : 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ANTERIOR SEGEMNET BY SLIT LAMP EXAMINATION: 
• NORMAL: 65 
• FINDINGS PRESENT: 11 
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ANTERIOR SEGMENT FINDINGS: 
• Normal                            : 65  
• Epithelial defect with uveitis  :  4 
• Old corneal opacity         :  2 
• Signs of active uveitis     : 1 
• Signs of chronic uveitis  : 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Anterior segment 
examination 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Normal 43 22 65 
Abnormal 3 8 11 
Total 46 30 76 
 
The chi-square value for the above table is 4.491 and the “P” value is 
0.034  
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POSTERIOR SEGMENT: 
• FINDINGS PRESENT: 13 
• NORMAL FUNDUS: 63 
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POSTERIOR SEGMENT FINDINGS: 
   
• COTTON WOOL SPOTS: 10 
• CHOROIDAL GRANULOMA (TUBERCULOMA): 2 
• DISC EDEMA WITH HEMORRHAGES AND EXUDATES: 1 
• NORMAL FUNDUS : 63 
 
 
 
 
 
 
 
 
 
 
 
0 10 20 30 40 50 60 70
Normal
Cotton wool spots ( both eyes)
Choroidal tuberculoma
Evidence of chronic 
papilloedema
Number of persons
P
o
st
er
io
r 
se
g
m
en
t 
fi
n
d
in
g
s
  
Posterior segment 
examination 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Normal 46 17 63 
Abnormal 0 13 13 
Total 46 30 76 
 
The chi - square value for the above table is 24.047   and the “P” value is 
0.000 
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VISUAL FIELDS: 
• FULL IN BOTH EYES: 71 
• ENLARGEMENT OF BLIND SPOT BOTH EYES: 1 
• ONE EYE FULL OTHER EYE CANNOT BE TESTED: 4 
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Visual fields 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Full 46 29 75 
Abnormal 0 1 1 
Total 46 30 76 
 
The chi-square value for the above table is 1.554 and the “P” value is 
0.213 
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SCHRIMERS TEST: 
• NORMAL:   74 
• EVIDENCE OF DRY EYE PRESENT: 2 
 
 
 
 
 
 
 
 
 
 
 
 
  
Schirmer’s test 
Without ocular 
manifestations 
With ocular 
manifestations 
Total 
Normal 46 28 74 
Abnormal 0 2 2 
Total 46 30 76 
 
 
 
The chi-square value for the above table is 3.150 and the “P” value is 
0.076  
 
 
 
 
 
 
 
  
FINAL OPHTHALMIC STATUS: 
• HIV RELATED OPHTHALMIC MANIFESTATION  
o PRESENT- 26 
o ABSENT - 46 
• NON HIV RELATED MANIFESTATION: 4 
 
 
 
 
 
 
 
 
  
OCULAR MANIFESTATIONS FOUND: 
I. HIV RELATED 
1. POSTERIOR SEGMENT MANIFESTATIONS: 
a. HIV related retinopathy : 10 (20 eyes)  
b. Choroidal tuberculoma : 2 (2 eyes) 
2. ANTERIOR SEGMENT MANIFESTATIONS: 
a. Herpes zoster ophthalmicus with Kerato uveitis :3 (3 eyes) 
b. Chronic uveitis : 1 (1 eye) 
c. Chronic keratitis: 1(1 eye) 
d. Acute anterior uveitis : 1(1 eye) 
3. ADNEXAL MANIFESTATIONS: 
a. Squamous cell carcinoma of conjunctiva : 4 (4 eyes) 
b. Dry eye : 2 (4 eyes) 
4. NEURO OPHTHALMIC MANIFESTATIONS: 
a. Chronic papilledema : 1 (2 eyes) 
b. Vertical gaze palsy : 1 (2 eyes) 
II. HIV NON RELATED 
1. Acute catarrhal conjunctivitis : 2 (4 eyes) 
2. Chalazion : 1(1 eye) 
3. Shield ulcer : 1 ( 1 eye) 
 
 
  
Ocular Manifestations (Total) 
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Final Ophthalmic diagnosis of the study group 
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Variable 
Number of 
persons without 
ocular 
manifestations 
Number of 
persons with 
ocular 
manifestations 
P value 
Gender 
Male: 34 19 
0.326 
Female: 12 11 
Age group 
< 30 7 8 
0.424 
31 – 40 18 9 
41 – 50 15 7 
51 – 60 6 5 
>60 0 1 
Socio economic status 
Class III 16 11 
0.867 
Class IV 30 19 
Marital status: 
Married 41 27 
0.422 Unmarried 4 1 
Widowed 1 2 
Mode of transmission: 
Heterosexual 45 28 
0.326 
Homosexual 1 2 
IV drug abuse 0 0 
Blood transfusion 6 4 
Tuberculosis 
Present 45 27 
0.135 
Absent 1 3 
CD4 count 
< 50 1 1 
0.414 
51 t0 100 3 4 
101 to 150 6 3 
151 to 200 3 0 
201 to 250 3 5 
≥ 250 30 17 
Stage of the disease 
Stage 1 35 17 0.045 
  
 
Stage 2 11 10 
Stage 3 0 0 
Stage 4 0 3 
Ocular symptoms: 
Nil 40 15 
0.012 
Defective vision 2 5 
Redness 3 3 
Irritation & FB 
sensation 
0 4 
Photophobia 0 2 
Floaters 0 0 
Others 1 1 
Visual acuity – RE 
6/6 – 6/18 39 28 
0.471 
<6/18 – 6/60 6 2 
<6/60 – 3/60 0 1 
<3/60 – 1/60 0 0 
<1/60 – NO PL 0 0 
Visual acuity – LE 
6/6 – 6/18 38 26 
0.276 
<6/18 – 6/60 4 2 
<6/60 – 3/60 1 0 
<3/60 – 1/60 0 2 
<1/60 – NO PL 0 3 
Lids and adnexa: 
Normal 38 18 
0.029 
Abnormal 8 12 
Anterior segment 
Normal 43 22 
0.034 
Abnormal 3 8 
Posterior segment 
Normal 46 17 
0.000 
Abnormal 0 13 
Schirmer’s test test 
Normal 46 28 
0.076 
Abnormal 0 2 
Visual fields 
Full 46 29 
0.213 
Abnormal 0 1 
  
                                         DISCUSSION 
In the present study out of 152 eyes examined of 76 patients 
abnormal ophthalmic findings were found in 42 eyes .The abnormal 
ophthalmic findings which are directly related to the HIV infection were 
seen in 37 eyes.  
PREVALANCE: 
The estimated prevalence of ophthalmic manifestations associated 
with HIV infection at the time of diagnosis is 24.34%. The prevalence of 
abnormal ocular findings seen in HIV positive patients at the time of 
diagnosis is 27.63%. 
There are many studies correlating the prevalence of Ophthalmic 
manifestations with HIV infection, but none were done to determine the 
ophthalmic status of the eye at the time of diagnosis. There is a study 
done by Sophia et al who determined the ophthalmic manifestations of 
HIV at the time of enrollment into ART Centre i.e. naïve to ART which 
proved the prevalence of ophthalmic manifestations to be 17.5%.  
PROFILE OF OCULAR MANIFESTATIONS: 
POSTERIOR SEGMENT MANIFESTATIONS: 
  
In our study, the prevalence of posterior segment manifestations 
(n=12) were more compared to anterior segment (n=6), which exactly 
matches with the study done by Sophia et al. Among the manifestations 
HIV retinopathy (n=10) is most common. In the study done by Sophia et 
al, CMV retinitis is the most common manifestation followed by HIV 
retinopathy. This can be related to the fact that in our study the mean 
CD4 count was greater than 100/cu.mm as all the patients were examined 
at the time of diagnosis only, whereas in their study prior to enrollment in 
ART center screening was done. The median range of CD4 count in our 
study is around 300 cells/cu.mm. Two patients had evidence of ocular 
tuberculosis in the form of choroidal tuberculoma, who also had evidence 
of coexisting systemic tuberculosis. This shows the importance of 
systemic tuberculosis as the major opportunistic infection among HIV 
positive persons in India.  
ANTERIOR SEGMENT MANIFESTATIONS: 
The number of patients with anterior segment and adnexal ocular 
lesions were 16 among which 12 had HIV related ocular lesions and 4 
had HIV non related ocular lesions. Among the twelve, 6 had anterior 
segment lesions and six had adnexal lesions. 
  
Six patients had ocular lesions relating to cornea and uvea of 
which three had Herpes zoster ophthalmicus, one had chronic uveitis, one 
with acute iritis and one had chronic keratitis.. Hence in our study the 
most common anterior segment finding which was more prevalent among 
HIV positive persons at the time of diagnosis is Herpes zoster 
Ophthalmicus keratouveitis.  
ADNEXAL MANIFESTATIONS: 
It was surprising to note that 4 patients had squamous cell 
carcinoma of conjunctiva who were diagnosed as seropositive for HIV on 
routine testing. It shows that Squamous cell carcinoma is more prevalent 
than Kaposi’s sarcoma in south Asian countries due to the low 
prevalence of human herpes virus type 8. Two patients had evidence of 
dry eye. 
NEURO OPHTHALMIC MANIFESTATIONS: 
Two patients had Neuro ophthalmological lesions which includes 
vertical gaze palsy and Chronic Papilledema due to tuberculous 
meningitis. The prevalence of Neuro ophthalmological lesions in our 
study is around 2.63%. 
 
  
DEMOGRAPHIC PROFILE: 
There was no significant association found between the patient and 
their demographic profile which includes age, sex, socio economic status 
and marital status. In the present study the prevalence of ocular 
manifestations in males and females among the entire study group were 
25 and 14.4% respectively. While the gender specific prevalence of 
ocular manifestations among males and females were 36 and 47% 
respectively. This skewed deviation was the limitation of the study and 
can be attributed to the fact that  the number of males who were enrolled 
for the study were more compared to females 
Among the modes of transmission, sexual transmission by 
heterosexual mode was found to be more common. But there was no 
association found between the occurrence of ocular manifestation and 
mode of transmission.  
CLINICAL STAGE, OCULAR SYMPTOMS, CO EXISTING 
HISTORY OF TUBERCULOSIS, CD4 COUNT: 
Four patients had concurrent history of pulmonary tuberculosis, 
among which two had evidence of ocular tuberculosis. However, No 
association was found between both.(p=0.135) 
  
There was major significant association found between the clinical 
stage of the disease and occurrence of ocular manifestation. (P =0.045). 
Most of the patients who got enrolled for the study belonged to clinical 
stage I and II respectively. This shows that ocular manifestations can 
occur even during the initial clinical stages itself. Hence the need for 
ophthalmic screening at the time of diagnosis.  
There was an association found between presence of ocular symptoms 
and the occurrence of ocular manifestations. (P=0.012). 
In the study by Sophia et al, the prevalence of ophthalmic 
manifestations in patients with CD4 count less than 200 cells/cu.mm was 
23.8%.  In our study, the prevalence of ophthalmic manifestations with 
CD4 count less than 200/cu.mm is 10.52%. There was no association 
found between CD4 count and occurrence of ocular manifestations. (P = 
0.414).  
OCULAR EXAMINATION AND MANIFESTATIONS: 
There was significant association found between lids and adnexal 
examination and occurrence of ocular manifestation. (P=0.029).Similarly 
between anterior segment examination and ocular manifestation 
(P=0.034), posterior segment examination and ocular manifestation 
(P=0.000) respectively.  
  
However, no association was found between Schrimers test and ocular 
manifestation (P=0.076) and also between visual field examination and 
ocular manifestation (P=0.213). 
VISUAL IMPAIRMENT: 
There was no association found between visual acuity and ocular 
manifestations. (P= 0.471 in right eye, P=0.276 in left eye). Among the 
76 patients, 65 had normal visual acuity, 10 had visual impairment and 1 
had severe visual impairment. However only 5 patients had evidence of 
visual impairment due to HIV related ocular manifestations. While the 
remaining 6 patients had preexisting ocular pathology including 
refractive error and cataract. Considering the visual disability, 5 patients 
had vision less than 3/60 in one eye other being normal (30% visual 
handicapped). Hence the prevalence of visual impairment due to HIV 
associated ocular manifestation is around 6.57%. 
 
        
 
                                                   
 
  
SUMMARY 
STUDY OBJECTIVE: 
1. To define the ocular manifestations of HIV/AIDS in adults at the 
time of diagnosis. 
2. To determine the prevalence of ocular manifestations of 
HIV/AIDS in adults at the time of diagnosis 
3. To correlate the manifestations with the demographic profile and 
clinical stage of the disease. 
4. To determine the visual impairment associated with ocular 
manifestations. 
STUDY DESIGN: 
A Cross sectional hospital based study. 
STUDY POPULATION: 
            A total of 76 persons who were diagnosed recently as HIV 
positive and attended the OP clinic of department of STD (sexually 
transmitted diseases) were screened for ophthalmic status with resources 
provided after getting a clear consent. 
  
STUDY RESULTS: 
Among the 76 persons examined 30 had ocular lesions; of which 
26 had HIV related ocular manifestations and 4 had HIV non related 
ocular manifestation. 12 had posterior segment and 12 had anterior 
segment lesions, while 2 had Neuro ophthalmological lesions. HIV 
retinopathy is the most common isolated ocular manifestation found in 
about 10 persons, whereas Kerato uveitis occurred in about 6 persons and 
squamous cell carcinoma of conjunctiva in about 4 persons. 
DISCUSSION: 
               Posterior segment manifestations accounts for the leading 
ocular manifestation as HIV retinopathy occurred in about 10 persons. 
There was no evidence of CMV retinitis in the study population as the 
mean CD4 count was above 300/cu.mm. Squamous cell carcinoma of 
conjunctiva occurred in 4 persons which shows the less prevalence of 
HHV 8 in India which causes Kaposi’s sarcoma, the leading HIV related 
ocular neoplasm in western countries 
 
 
                                                
  
                                               CONCLUSION 
The Ophthalmic manifestations occurring in adults due to HIV 
infection involve all the four groups – adnexa, anterior segment, posterior 
segment and Neuro ophthalmological manifestations. However, it’s the 
posterior segment manifestations which were found to be more prevalent.  
No significant association was found with the demographic profile, 
mode of transmission and concurrent history of tuberculosis. Though, 
significant association was found with clinical stage of the disease and 
the concomitant presence of ocular symptoms. 
No evidence of opportunistic infections other than ocular 
tuberculosis was found was as the median CD4 count was above 
300/cu.mm. Also no association between ocular manifestation and CD4 
count was found as most patients had CD4 count more than 300/cu.mm. 
This also signifies most patients were diagnosed earlier even before they 
develop advanced disease and less CD4 counts. However, most patients 
were unaware of their ophthalmic status and the need for screening which 
shows significant association between ocular manifestation and the 
screening procedures (slit lamp examination, fundus examination, and 
adnexal examination) in the present study. 
  
Hence, the present study strongly emphasizes the importance of 
routine ophthalmic screening at the time of diagnosis of HIV 
seropositivity in adults. 
 
 
 
 
 
 
 
 
 
 
 
 
  
CLINICAL PICTURES: 
Choroidal tuberculoma (fundus picture) 
 
FFA findings 
 
 
  
Herpes zoster Ophthalmicus: 
 
CHRONIC KERATITIS: 
 
 
 
  
SQUAMOUS CELL CARCINOMA: 
 
 
After excision 
 
                              
 
 
 
 
 
  
HIV Retinopathy: 
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PROFORMA – THESIS: 
Name of the patient: 
Age:                              sex:                   Occupation:                    Marital 
status: 
SES:                                       OP no:                         Date of diagnosis: 
CD4 count:                                   Clinical stage of the disease: 
Ocular symptoms:      present/absent 
          Detailed history of symptoms: 
 
 
History of Tuberculosis:  present/absent       on ATT or not 
Sexual history:      premarital/extra marital        homosexual/heterosexual 
History of IV drug abuse/blood transfusion 
 
 
  
OCULAR EXAMINATION: 
Best corrected visual acuity- right eye:                    left eye: 
Lids and adnexal examination by torch light: 
 
Anterior segment examination by slit lamp: 
 
Visual fields by Bjerrum screen:     RE:                     LE: 
Schrimers test RE:                LE: 
Fundus examination:    Direct ophthalmoscope-  RE:               LE: 
With 90 D -    RE:                      LE: 
                                    With indirect ophthalmoscope -    RE:             LE: 
 FINAL OPHTHALMIC STATUS: 
 
 
  
 
Key to Master Chart: 
MS – Marital status         
MR- Married     
U- Unmarried       
W- Widowed 
SES – Socio Economic Status  
SXH – Sexual history  
HT- Heterosexual  
HO-Homosexual    
SYMP Y/N – symptoms present/absent  
IRR- irritation 
RED – redness  
PHB – photophobia  
DV – defective vision  
  
WAT – watering 
FB- foreign body sensation 
 P – Pain  
DIS – discharge  
H- Headache  
S- Swelling 
TB – tuberculosis 
STG – clinical stage of the disease 
BT – blood transfusion 
IVD – intravenous drug abuse 
VA – visual acuity 
RE – right eye 
LE – left eye 
BE – both eyes 
ANT SEG – anterior segment 
  
POS SEG – posterior segment 
L & A – lids and adnexa 
CCC – circum corneal congestion 
CONJ – conjunctiva 
CWS – cotton wool spots 
VGP – vertical gaze palsy 
PAP – papilledema 
F – flare 
C- cells 
KP- keratic precipitates 
HZO – herpes zoster ophthalmicus 
KU- keratouveitis 
SCH – Schrimer’s test 
D & T CV- dilated and tortuous conjunctival vessels. 
HERP LES – herpetic lesions 
  
OLD OPA – old corneal opacity 
SN – solitary nodule 
Q – Quadrant 
ACCO – acute catarrhal conjunctivitis. 
CHO TB WIT ERD – choroidal tuberculoma with exudative retinal 
detachment 
SCC- squamous cell carcinoma. 
 
 
 
 
 
 
 
 
 
  
master chart 
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ST
G VA L & A 
ANT 
SEG 
POS 
SEG 
FIELD
S 
SC
H FINAL 
1 F 47 W IV S08821 136 N NIL HT NIL 
NI
L II 6/6 BE N N 
 BE 
CWS + FULL N HR BE 
2 F 38 Mr IV S08345 242 Y- IRR BE NIL HT NIL 
NI
L I 6/6 BE N N N FULL DE 
DRY EYE 
BE 
3 M 39 Mr IV S09256 242 N NIL HT NIL 
NI
L I 6/6 BE N N N FULL N N STUDY 
4 M 58 Mr III S08618 402 N NIL HT NIL Y I 6/9 BE N N N FULL N N STUDY 
5 M 29 Mr III S02370 509 N NIL HT NIL 
NI
L I 6/6 BE N N N FULL N N STUDY 
6 F 39 Mr IV S08614 408 N NIL HT NIL 
NI
L I 6/6 BE N N N FULL N N STUDY 
7 M 60 Mr IV OP N 14330 320 
Y RED & 
PHB, DV 
LE NIL HT NIL Y II 
6/36 
2/60 
HERP LES+  
CCC+ 
ED+ 
KPS+  N FULL N HZV KU LE 
8 M 53 Mr IV S N 639/12 336 
Y RED & 
PHB LE NIL HT NIL Y II 
6/18 
6/12P 
HERP LES+ 
CCC+ 
EPI DEF+ 
KPS+ F 
1+ C 1+ N FULL N HZV KU LE 
9 F 50 W IV S05636 825 N NIL HT NIL Y I 
6/6P 
BE D & T CV+ N N FULL N N STUDY 
10 M 55 Mr IV 
PE 112899 
DIAGNSED 
OUTSIDE 312 Y H NIL HT NIL 
NI
L I 
6/6P  
6/9P N N 
CWS 
BE + FULL N HR BE 
11 M 31 Mr III S09024 161 N NIL HT NIL 
NI
L I 6/6 BE N N N FULL N N STUDY 
12 M 37 Mr III so8290 301 N NIL HT NIL 
NI
L I 6/9 BE N N N FULL N N STUDY 
13 M 45 Mr III S06153 164 N NIL HT NIL 
NI
L I 6/6 BE N N N FULL N N STUDY 
14 M 33 Mr IV S07626 423 N NIL HT NIL 
NI
L I 6/6 BE N N N FULL N N STUDY 
  
15 F 70 W IV S09092 854 
Y - DV, 
RED, 
PHB LE NIL HT NIL Y II 
6/12 
HM+ 
CCC+ HERP 
LES+ 
EPI DEF+ 
F 2+ C 2+ N 
RE FULL 
LE CBT N HZV KU LE 
 
16 F 46 Mr III S08254 285 N NIL HT NIL NIL I 6/6 BE N N N FULL N N STUDY 
17 F 36 Mr III S08961 55 N 
POSITIVE 
ON ATT HT NIL NIL IV 6/6 BE BITOT SPOTS+ N 
SN ST 
Q LE FULL N CHO TB LE 
18 M 36 Mr III SO9077 280 DV LE NIL HT NIL NIL I 
6/36 
HM+ CCC+ EPI DEF+ N 
RE FULL 
LE CBT N 
SHIELD 
ULCER LE 
19 M 56 Mr IV S08564 212 
RED P W 
LE NIL HT NIL NIL I 
6/9 
6/6P PAPILLAE+ N N FULL N N STUDY 
20 F 30 Mr IV S08959 47 N NIL HT NIL NIL I 
6/9P 
6/9 N N 
CWS 
BE + FULL N HR BE 
21 M 39 Mr III S08940 300 N NIL HT NIL NIL I 6/6 BE D & T CV N N FULL N N STUDY 
22 M 52 Mr IV S03613 237 N NIL HT NIL NIL II 
6/12 
6/18 N N 
CWS 
BE+ FULL N HR BE 
23 M 38 Mr III S08824 253 N NIL HT NIL NIL I 
6/6P 
6/6 D & T CV+ N N FULL N N STUDY 
24 M 36 Mr III S08934 145 N NIL HT NIL NIL I 6/6 BE N N N FULL N N STUDY 
25 M 33 Mr III S08929 270 N NIL HT NIL NIL II 6/6 BE N N N FULL N N STUDY 
26 F 34 Mr IV S07613 330 N NIL HT NIL NIL II 6/6 BE N N N FULL N N STUDY 
27 F 33 Mr IV S05636 210 N NIL HT NIL' NIL I 
6/9P 
6/6 N N N FULL N N STUDY 
28 M 30 Mr IV S08909 87 N NIL HT NIL NIL II 
6/24P 
BE N N N FULL N N STUDY 
29 M 50 Mr IV S08925 120 N NIL HT NIL Y II 
6/60 
4/60 N N N FULL N N STUDY 
30 M 37 Mr IV S08567 87 DV LE NIL HT NIL NIL II 6/6 BE N N N FULL N N STUDY 
31 M 29 Mr IV S07666 286 N NIL HO NIL NIL I 6/6 BE N N N FULL N N STUDY 
32 M 57 Mr IV S08946 49 N NIL HT NIL NIL I 6/12 N N N FULL N N STUDY 
  
6/6 
33 F 26 U IV S05935 285 N NIL HT NIL NIL II 6/6 BE N N N FULL N N STUDY 
34 M 50 Mr IV S08847 141 N NIL HT NIL NIL I 
6/36 
6/18 N N N FULL N N STUDY 
35 M 41 Mr IV S07852 532 N NIL HT NIL NIL I 6/6 BE N N N FULL N N STUDY 
36 F 30 Mr III S06150 331 N NIL HO NIL NIL I 6/6 BE N N 
CWS 
BE + FULL N HR BE 
37 M 48 Mr III S08840 82 
Y DV 
PHB LE NIL HT NIL NIL II 
6/18 
6/36 CCC+ 
EPI DEF+ 
F2+ C2+ N FULL N CHR KER LE 
38 M 45 Mr IV S08757 457 N NIL HT NIL NIL I 6/6 BE N 
OLD OPA  
IQ+ N FULL N N STUDY 
39 F 47 Mr IV S08897 226 N NIL HT NIL NIL I 
6/12 
6/24 N N N FULL N N STUDY 
40 M 43 Mr IV OP N 15444 102 
RED PHB 
DV LE NIL HO NIL NIL II 
6/24 
1/60 CCC+ 
OLD 
KPS+ PS+ N 
 RE 
FULL LE 
CBT N CHR UVE LE 
41 F 22 U III S08692 317 N NIL HT NIL Y I 6/6 BE N N N FULL N N STUDY 
42 M 45 Mr III S09227 79 H 
POSITIVE 
ON ATT HT NIL NIL IV 
6/9 
6/6 N N DE BE+,  
EBS 
BE+ N 
CHR PAP 
BE 
43 M 39 Mr IV S03557 85 
DV P 
PHB LE 
POSITIVE 
ON ATT HT NIL NIL IV 
6/6 
HM+ CCC+ 
OLD 
KPS+ PS+ 
EG IN 
ST Q 
WITH E 
RD IN 
LE+ 
RE FULL 
LE CBT N 
CHO TB 
WITH ERD 
LE 
44 M 47 Mr IV S08923 402 
RED DIS 
RE 
POSITIVE 
ON ATT HT NIL NIL I 
6/9 
6/12 
CONJ 
CONGESTION+ N N FULL N ACCO BE 
45 F 21 U IV S01415 451 
IRR FB 
BE NIL HT NIL NIL I 6/6 BE N N N FULL DE DRY EYE BE 
46 F 27 Mr IV S05108 252 N NIL HT NIL' NIL I 6/6 BE N N 
CWS 
BE+ FULL N HR BE 
47 M 40 Mr IV S01925 140 N NIL HT NIL NIL I 6/6 BE N N N FULL N VGP BE 
48 M 47 Mr IV S09341 452 N NIL HT NIL NIL I 6/6 BE N N CWS FULL N HR BE 
  
BE+ 
49 F 34 Mr III S08412 312 P RED BE NIL HT NIL NIL I 
6/18 
6/36 
CONJ 
COGESTION+ N N FULL N ACCO BE 
50 M 40 Mr IV S06991 620 N NIL HT NIL NIL I 
6/12 
6/9 N N N FULL N N STUDY 
51 M 32 Mr III OP N 01891 381 N NIL HT NIL NIL I 
6/6 
6/12 N N N FULL N N STUDY 
52 M 47 Mr IV S08866 97 N NIL HT NIL NIL II 6/6 BE N N N FULL N N STUDY 
53 M 35 Mr III S02278 327 S LE NIL HT NIL NIL I 
6/6 
6/12 CHALAZION LE N N FULL N 
CHALAZION 
LE 
54 F 42 Mr IV S07957 302 N NIL HT NIL NIL I 
6/9 
6/9 N N N FULL N N STUDY 
55 M 38 Mr III OP N 6124 920 
IRR RED 
LE NIL HT NIL NIL I 
6/18 
BE 
RAISED CONJ 
LES+ LE N N FULL N SCC LE 
56 F 31 Mr III S01068 381 
RED P 
PHB LE NIL HT NIL NIL I 
6/6 
6/12 CCC+ 
KPS+ 
C1+ F1+ N FULL N AC IRI LE 
57 M 45 Mr IV OP N 6493 285 
IRR RED 
LE NIL HT NIL NIL II 
6/6P 
BE 
RAISED CONJ 
LES+ RE N N FULL N SCC RE 
58 M 42 Mr IV S06410 400 N NIL HT NIL NIL I 
6/18 
6/9 N N N FULL N N STUDY 
59 F 36 Mr III S08492 168 N NIL HT NIL NIL I 6/6 BE N N N FULL N N STUDY 
60 M 55 Mr IV S08750 121 N NIL HT NIL Y II 6/6 BE N N N FULL N N STUDY 
61 M 48 Mr IV 
P 3749 
(DIAGNSED 
OUTSIDE) 341 N NIL HT NIL NIL II 
6/18 
6/12 N 
OLD OPA 
IQ RE+ N FULL N N STUDY 
62 F 40 Mr IV S09302 282 N NIL HT NIL NIL I 
6/9 
6/9 N N N FULL N N STUDY 
63 M 25 U III S09301 133 N NIL HT NIL NIL II 6/6 BE N N N FULL N N STUDY 
64 M 46 Mr IV S09299 108 N NIL HT NIL NIL II 6/9 BE N N N FULL N N STUDY 
65 M 40 Mr IV S09724 620 N NIL HT NIL NIL I 
6/12 
6/9P N N N FULL N N STUDY 
66 F 56 Mr IV S09231 328 N NIL HT NIL Y I 
6/24 
BE N N N FULL N N STUDY 
  
67 M 60 Mr IV S09041 412 N NIL HT NIL Y I 
6/36 
BE N N N FULL N N STUDY 
68 M 58 Mr IV S09349 402 N NIL HT NIL NIL I 
6/12 
BE N N N FULL N N STUDY 
69 F 25 Mr III S07404 205 N NIL HT NIL NIL II 6/9 BE N N 
CWS 
BE + FULL N HR BE 
70 M 24 Mr III S08232 215 N NIL HT NIL NIL I 6/6 BE N N 
CWS 
BE+ FULL N HR BE 
71 M 25 U III S09198 401 N NIL HT NIL NIL I 6/6 BE N N N FULL N N STUDY 
72 M 30 Mr IV S08450 414 N NIL HT NIL NIL I 6/6 BE N N N FULL N N STUDY 
73 M 44 Mr IV S06335 321 N NIL HT NIL NIL I 
6/24 
BE N N N FULL N N STUDY 
74 M 28 Mr III S09352 302 N NIL HT NIL NIL I 6/6 BE N N 
CWS 
BE+ FULL N HR BE 
75 M 50 Mr IV S06734 312 
RED IRR 
RE NIL HT NIL NIL II 
6/12 
6/9 
RAISED LES 
CONJ RE+ N N FULL N SCC RE 
76 M 40 Mr IV S07532 345 
IRR RED 
RE NIL HT NIL NIL I 6/9 BE 
RAISED LES 
CONJ+ LE N N FULL N SCC LE 
 
 
